The adverse effects of vitrification on mouse embryo development and metabolic phenotype in offspring.
Qiaoyu ChenDan ZhouChangxin WangMingming YeYanping JiaBinya LiuOrhan BukulmezRobert J NormanHanxin HuShu-Biu YeungXiaoming TengWenqiang LiuMiaoxin ChenPublished in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology (2023)
Embryo vitrification is a standard procedure in assisted reproductive technology. Previous studies have shown that frozen embryo transfer is associated with an elevated risk of adverse maternal and neonatal outcomes. This study aimed to explore the effects of mouse blastocyst vitrification on the phenotype of vitrified-warmed blastocysts, their intrauterine and postnatal development, and the long-term metabolic health of the derived offspring. The vitrified-warmed blastocysts (IVF + VT group) exhibited reduced mitochondrial activity, increased apoptotic levels, and decreased cell numbers when compared to the fresh blastocysts (IVF group). Implantation rates, live pup rates, and crown-rump length at E18.5 were not different between the two groups. However, there was a significant decrease in fetal weight and fetal/placental weight ratio in the IVF + VT group. Furthermore, the offspring of the IVF + VT group at an age of 36 weeks had reduced whole energy consumption, impaired glucose and lipid metabolism when compared with the IVF group. Notably, RNA-seq results unveiled disturbed hepatic gene expression in the offspring from vitrified-warmed blastocysts. This study revealed the short-term negative impacts of vitrification on embryo and fetal development and the long-term influence on glucose and lipid metabolism that persist from the prenatal stage into adulthood in mice.
Keyphrases
- pregnancy outcomes
- single cell
- rna seq
- high fat diet
- pregnant women
- gene expression
- healthcare
- physical activity
- body mass index
- public health
- weight loss
- cell death
- dna methylation
- type diabetes
- adipose tissue
- emergency department
- oxidative stress
- metabolic syndrome
- cell therapy
- skeletal muscle
- minimally invasive
- bone marrow
- body weight
- climate change
- preterm birth
- adverse drug